Crucially, the long-acting insulin was no worse than Tresiba when it came to rates of ... versus 0.27 events for the once-daily drug. Novo Nordisk said that if approved for use, insulin icodec ...

Tresiba, a daily basal insulin injection ... with promising results also annouced for its oral drug Semaglutide. One of the first acts of President Donald Trump after his inauguration yesterday ...